Back to Results
First PageMeta Content
Glycoproteins / Medicine / Symphogen / Biotechnology / Antibody / Genentech / Monoclonal antibody therapy / Polyclonal antibodies / John McCafferty / Immunology / Biology / Immune system


Symphogen Enters into strategic collaboration with Genentech for antibody therapeutics SYMPHOGEN ENTERS INTO STRATEGIC COLLABORATION WITH GENENTECH FOR ANTIBODY THERAPEUTICS IN INFECTIOUS DISEASE COPENHAGEN, Denmark –
Add to Reading List

Document Date: 2014-10-27 08:46:29

Open Document

File Size: 46,61 KB

Share Result on Facebook
UPDATE